NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting
Communications Biology · 2024
DOI: 10.1038/s42003-024-05798-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Communications Biology, 2024. Verfasst von Swati Sharma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 6997801, Israel. Hauptthemen laut MEDLINE: Endoglin, Neuropilin-1, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor Receptor-2. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: US-Israel Binational Science Foundation.
Abstract (Originalsprache)
Endothelial cells express neuropilin 1 (NRP1), endoglin (ENG) and vascular endothelial growth factor receptor 2 (VEGFR2), which regulate VEGF-A-mediated vascular development and angiogenesis. However, the link between complex formation among these receptors with VEGF-A-induced signaling and biology is yet unclear. Here, we quantify surface receptor interactions by IgG-mediated immobilization of one receptor, and fluorescence recovery after photobleaching (FRAP) measurements of the mobility of another coexpressed receptor. We observe stable ENG/NRP1, ENG/VEGFR2, and NRP1/VEGFR2 complexes, which are enhanced by VEGF-A. ENG augments NRP1/VEGFR2 interactions, suggesting formation of tripartite complexes bridged by ENG. Effects on signaling are measured in murine embryonic endothelial cells expressing (MEEC +/+ ) or lacking (MEEC -/- ) ENG, along with NRP1 and/or ENG overexpression or knockdown. We find that optimal VEGF-A-mediated phosphorylation of VEGFR2 and Erk1/2 requires ENG and NRP1. ENG or NRP1 increase VEGF-A-induced sprouting, becoming optimal in cells expressing all three receptors, and both processes are inhibited by a MEK1/2 inhibitor. We propose a model where the maximal potency of VEGF-A involves a tripartite complex where ENG bridges VEGFR2 and NRP1, providing an attractive therapeutic target for modulation of VEGF-A signaling and biological responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 6997801, Israel.
- Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 6997801, Israel.
- Department of Medicine, Duke University Medical Center, Durham, NC, 27708, USA.
- Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27708, USA.
- Department of Neurobiology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, 6997801, Israel. yoavhe@tauex.tau.ac.il.
ORCID-Profile: Marcelo Ehrlich, Yoav I Henis
Förderung
- US-Israel Binational Science Foundation
Zitieren
APA
Sharma, S., Ehrlich, M., Zhang, M., Blobe, G. C., & Henis, Y. I. (2024). NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting. Communications Biology. https://doi.org/10.1038/s42003-024-05798-2
Vancouver
Sharma S, Ehrlich M, Zhang M, Blobe GC, Henis YI. NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting. Communications Biology. 2024. doi:10.1038/s42003-024-05798-2
BibTeX
@article{Sharma2024,
author = {Sharma, Swati and Ehrlich, Marcelo and Zhang, Manqi and Blobe, Gerard C and Henis, Yoav I},
title = {NRP1 interacts with endoglin and VEGFR2 to modulate VEGF signaling and endothelial cell sprouting},
journal = {Communications Biology},
year = {2024},
doi = {10.1038/s42003-024-05798-2}
}
EUVIMED